Speaker illustration

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

P. Gabriel Steg, MD, FESC, FACC Born Feb 16, 1959 Université de Paris, INSERM U-1148, Département de Cardiologie, Hôpital Bichat Assistance Publique - Hôpitaux de Paris 46, rue Henri Huchard, 75877 Paris cedex 18, France Phone: +33 1 40 25 86 68, Fax : +33 1 40 25 88 65 E-mail: gabriel.steg@aphp.fr Affiliations - Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France. - Vice President (in charge of research) of the board of Assistance Publique-Hôpitaux de Paris since 2018. - Professor of Cardiology at Université Paris - Diderot, since 1994. - Director of the “Clinical Research in Atherothrombosis” Research Team, INSERM Unit U1148, Paris - co-coordinator of the Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation and REmodeling). - Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) RHU research consortium. - Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic resea

Late Breaking Trials in ACS

Event: ESC Congress 2021 - The Digital Experience

Topic: Acute Coronary Syndromes

Session type: Late-Breaking Science

Thumbnail

Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiovascular Risk Assessment

Session type: Industry Q&A session

Thumbnail

Hot Line Session 6

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology, Other

Session type: Late-Breaking Science

Thumbnail

Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Event: ESC CONGRESS 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data

Event: ESC Congress 2018

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium

Thumbnail

Starting, stopping, and everything in between: recent data concerning dual antiplatelet therapy in ACS

Event: ESC CONGRESS 2017

Topic: Thrombosis and platelets

Session type: Symposium

Thumbnail

Meet the Guidelines task force - Focused update on dual antiplatelet therapy developed in collaboration with EACTS

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session type: Special Session

Thumbnail

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Event: ESC CONGRESS 2017

Topic: Thrombosis and platelets

Session type: Satellite Symposium

Thumbnail

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Event: ESC CONGRESS 2017

Topic: Thrombosis and platelets

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

This platform is supported by

logo Novo Nordisk